Patient with history of myelomonocytic leukemia post treatment, below is a follow up flow cytometry analysis of his peripheral blood months later, showing an expanded population in the CD45-dim gate (aka "blast-gate") #hemepath #PathTwitter #leusm #MedEd #MedTwitter #MedX @saada_vsaada
This population is negative for CD14, CD33, CD34, C64, CD117, CD123 & HLA-DR expression; However, it shows subset CD13 expression #hemepath #PathTwitter #leusm #MedEd #MedTwitter #MedX
Dec 17, 2023 • 7 tweets • 2 min read
Viral infections may show striking T-cell atypia; which in the absence of adequate clinical history, may be worked-up for T-cell lymphoma
Below are pictures from a peripheral blood smear of a patient with an acute viral illness & remarkable lymphocytic atypia #hemepath #lymsm
Flow cytometry analysis confirms the nature of these numerous atypical cells by morphology as lymphocytes, with a predominant CD3-positive T-cell population #hemepath #lymsm #PathTwitter #PathX #SoMe #MedTwitter
Dec 11, 2023 • 12 tweets • 4 min read
Tricky case of Cyclin-D1-positive neoplasm➡️
Patient presented with "pancytopenia, rule out MDS"
Flow cytometry of a limited marrow aspirate revealed a CD20-positive Kappa restricted population that appeared to be negative for CD19 expression #hemepath #lymsm #mmsm #MedTwitter
Morphologic examination showed a hypercellular marrow almost completely involved by a "lymphoid" infiltrate with a low grade morphology
Nov 30, 2023 • 13 tweets • 4 min read
An incredibly challenging case of ALK-rearranged poorly differentiated lung adenocarcinoma with diffuse CD30 positivity, mimicking ALK-rearranged Anaplastic Large Cell Lymphoma, first authored by future #hemepath🌟@gibyvgeorge ➡️ #lymsm @Histo_Journalonlinelibrary.wiley.com/doi/10.1111/hi…
Patient presented with a mediastinal mass, composed of sheets of anaplastic cells. Cytokeratin stains along with CD45 & all B-cell & T-cell markers were negative
#hemepath #lymsm #pathtwitter #pathX #molpath #medtwitter #surpath #cytopath #thoracicpath
Nov 29, 2023 • 9 tweets • 4 min read
Patient with history of CLL/SLL clinically progressing; Below bone marrow biopsy shows complete involvement by lymphoma
#lymsm #hemepath #PathTwitter #pathx #surgpath #MedTwitter #bmtsm
High power evaluation: 2 components detetcted, the yellow circle is the CLL/SLL component, and the yellow arrows point at larger pleomorphic cells #lymsm #hemepath #PathTwitter #pathx #surgpath #MedTwitter #bmtsm
Nov 27, 2023 • 8 tweets • 3 min read
CLL/SLL with an inter & peri-follicular architecture ⬇️⬇️
#hemepath #PathTwitter #lymsm #pathX #surgpath
The neoplastic lymphocytes surround germinal centers; If the neoplastic cells had more of a "monocytoid" look, with this perifollicular architecture, this lymphoma could be easily misinterpreted as nodal marginal zone lymphoma, particularly in limited core-nedle biopsy
#hemepath
Nov 25, 2023 • 16 tweets • 6 min read
Stage III Hematogones can express CD5, and this may cause overinterpretation as residual CD5+ B-cell lymphoma. Let's go through 2 examples below that nicely illustrate this⬇️
@ICCS_Education @saada_vsaada #hemepath #Xpath #PathTwitter #MedTwitter #surgpath #lymsm
In the example below of a bone marrow flow cytometry analysis, SCC against CD45 plot, you can nicely see the 3 stages of Hematogones, with stage 3 blending in with mature B-lymphocytes #hemepath #Xpath #PathTwitter #MedTwitter #surgpath #lymsm #leusm
Nov 23, 2023 • 4 tweets • 2 min read
CLL/SLL initially presenting as skin lesions, with plasmacytic differentiation, real entity or myth?
🩸Below is an illustration of low grade B-cell lymphoma with a CLL phenotype & monotypic plasma cells
🩸CD5+ LPL is on top of the differential & must be ruled out, as do as low grade B-cell lymphomas that can show common features with CLL phenotype
🩸Mantle cell lymphoma & follicular lymphoma can also demonstrate plasmacytic differentiation
#hemepath #PathTwitter #lymsm
Nov 19, 2023 • 9 tweets • 3 min read
Have you had a pediatric B-ALL with very mature features previously, that made you question whether you are dealing with a B-cell lymphoma instead? Below is a similar case:
Starting with CD38 expression: It is not as "dim" as you would expect it to be in B-ALL
#Hemepath #Leusm
Moving to CD10, which is considered a marker of immaturity, it is absent below
It is known that B-ALL with KMT2A rearrangement may undergo lineage switch after therapy. See below a KMT2A-R B-ALL case switching to an AML (CD34+ HLA-DR+) after treatment, then switching to a monocytic leukemia (CD14+ CD64+/CD34- HLA-DR-) 2 years later
#hemepath @ICCS_Education
Starting with the B-ALL at presentation, positive for CD19, CD22 & CD79a
(1/6) Future #dermpath star, @DermpatGal, & I have put together an illustration of hematologic findings in "Drug Reaction with Eosinophilia & Systemic Symptoms" (DRESS) @AjHematology ➡️ bit.ly/3u9WvLa
#Tweetorial ⬇️
(2/6) Drug metabolites (commonly of anti-anticonvulsant medication) are thought to stimulate T-cells leading to a florid immune response/ or cause viral activation (HHV6) leading to downstream immune activation
One of the many pearls that I learned from @ljmedeirosMD is:"The best time to learn, is after you know the diagnosis of a case, by going back to the slides and reading more about it".In this spirit, below are the answers of today's cases, with pictures #hemepath@KirillLyapichev